PRESS RELEASE published on 02/20/2025 at 18:30, 1 year 2 months ago Inside Information / Operations of the issuer (acquisitions, sales...) Theraclion secures financing of €6 million through a convertible bond loan with firm commitments from historical shareholders, Furui and Unigestion. CEO Martin Deterre highlights strategic priorities for revenue growth and FDA approval Financing Strategic Priorities FDA Approval Theraclion Convertible Bond Loan
PRESS RELEASE published on 02/20/2025 at 18:30, 1 year 2 months ago Informations privilégiées / Opérations de l'émetteur (acquisitions, cessions...) Theraclion sécurise un financement de 6 millions d'euros auprès de ses actionnaires historiques grâce à un emprunt obligataire convertible. Objectif : poursuite R&D et développement commercial Actionnaires Financement Emprunt Theraclion Obligataire Convertible
BRIEF published on 02/07/2025 at 18:35, 1 year 3 months ago Publication des comptes ajustés de Theraclion pour le premier semestre 2024 Trésorerie Theraclion Comptes Ajustés Ultrasons Focalisés Marche Des Varices
BRIEF published on 02/07/2025 at 18:35, 1 year 3 months ago Publication of Theraclion's adjusted accounts for the first half of 2024 Treasury Theraclion Adjusted Accounts Focused Ultrasound Varicose Veins Walk
PRESS RELEASE published on 02/07/2025 at 18:30, 1 year 3 months ago Informations privilégiées / Communiqué sur comptes, résultats Publication des comptes ajustés du premier semestre 2024 de Theraclion, société innovante en thérapie ultrasonique pour varices. Focus sur recentrage stratégique et résultats financiers Stratégie Résultats Financiers Theraclion Varices Comptes Ajustés
BRIEF published on 01/06/2025 at 19:06, 1 year 4 months ago Theraclion 2024 Review: Progress and Challenges Turnover Theraclion SONOVEIN® FDA Clinical Trial Product Maturity
BRIEF published on 01/06/2025 at 19:06, 1 year 4 months ago Bilan 2024 de Theraclion : avancées et défis Chiffre D'affaires Theraclion SONOVEIN® Essai Clinique FDA Maturité Produit
PRESS RELEASE published on 01/06/2025 at 19:01, 1 year 4 months ago Informations privilégiées / Communiqué sur comptes, résultats THERACLION fait le bilan de ses réalisations en 2024, mettant en avant les avancées de son essai clinique pivot FDA et la maturité de son produit SONOVEIN® pour traitement des varices 2024 Essai Clinique Theraclion SONOVEIN® Varices
BRIEF published on 10/30/2024 at 19:05, 1 year 6 months ago Theraclion: Results for the First Half of 2024 and Strategic Outlook Financial Results Theraclion SONOVEIN FDA America Marketing 2025
BRIEF published on 10/30/2024 at 19:05, 1 year 6 months ago Theraclion : Résultats du Premier Semestre 2024 et Perspectives Stratégiques Résultats Financiers Theraclion SONOVEIN FDA Amérique Commercialisation 2025
Published on 05/08/2026 at 15:55, 1 hour 16 minutes ago Class 1 Nickel and Technologies Ltd. Announces Private Placement and Share for Debt Offering
Published on 05/08/2026 at 15:00, 2 hours 11 minutes ago Jaguar Health Regains Compliance with Nasdaq's Publicly Held Shares Requirement and Receives Additional Extension, Until May 18, 2026, to Demonstrate Compliance with Nasdaq's Bid Price Rule
Published on 05/08/2026 at 14:55, 2 hours 16 minutes ago Nepra Foods Inc. to Present at the 16th Annual LD Micro Invitational
Published on 05/08/2026 at 14:30, 2 hours 41 minutes ago Unusual Machines Hosts Live Drone Ecosystem Demonstrations at XPONENTIAL 2026
Published on 05/08/2026 at 14:00, 3 hours 11 minutes ago BlackBerry Announces Renewal of Normal Course Issuer Bid Share Buyback Program
Published on 05/08/2026 at 17:00, 11 minutes ago Drägerwerk AG & Co. KGaA: Dräger’s annual shareholders’ meeting resolves on a significant dividend increase
Published on 05/08/2026 at 16:35, 36 minutes ago Edison issues report on Canadian General Investments (CGI)
Published on 05/08/2026 at 16:15, 56 minutes ago Inaugural Global Mediation Summit boosts Hong Kong’s status as a global mediation hub
Published on 05/08/2026 at 16:15, 56 minutes ago Lonza Announces Results of the 2026 Annual General Meeting – All Motions Proposed by Board of Directors Approved
Published on 05/08/2026 at 16:15, 56 minutes ago DATAGROUP Acquires Dutch IT Service Provider Valid Managed Services
Published on 05/07/2026 at 19:15, 21 hours 56 minutes ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 21 hours 56 minutes ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 22 hours 5 minutes ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 22 hours 5 minutes ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 22 hours 11 minutes ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
